PRECISE Studies

Lowering Thermal Damage Improves Outcomes

The PRECISE family of clinical studies encompasses our research in plastic, breast, orthopedic, ENT and oncologic surgery. This work has demonstrated that the PEAK PlasmaBlade produces significantly improved post-operative outcomes in humans compared to the standard of care technology. Additional pre-clinical research in animal models has supported these results.

The first PRECISE study - a randomized, controlled trial(RCT) of patients undergoing abdominoplasty -demonstrated significantly improved narcotic consumption & pain scores, return to normal activity and diet volume levels, and less blood loss compared to scalpel and traditional electrosurgery.

The results of this study were presented at the American College of Surgeons and European Society of Plastic, Reconstructive and Aesthetic Surgery 2009 annual meetings.

Additional studies in orthopedic surgery⁴ are examining the effects of less inflammation on recovery from total joint replacement (TJR). In breast reduction⁵ and mastectomy⁶,preliminary study results have demonstrated that the PlasmaBlade improves cutting performance and de-epithelialization by over 30% compared to traditional electrosurgery.

For more information about PEAK Surgical's Clinical Research Program, please contact Dominique Atmodjo, C.C.R.A., at datmodjo@peaksurgical.com or the Medical Director, Josh Vose M.D., at jvose@peaksurgical.com

Learn More About PEAK Surgical:

• For publications describing the clinical use of PEAK's technology, click here.
• The PlasmaBlade family of surgical devices
• PEAK's surgical technology for minimally invasive surgery and bleeding control
• PEAK Surgical - Medical Device Company Overview